RENE | Cartesian Growth Corporation II Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	11.66 - 11.66
52 Week Range	10.93 - 11.67
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	209
Average Volume	85,968
Shares Outstanding	12,999,710
Market Cap	151,576,619
Sector	Financial Services
Industry	Shell Companies
IPO Date	2022-07-08

Valuation
Profitability
Growth
Health
P/E Ratio	26.50
Forward P/E Ratio	N/A
EPS	0.44
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	2
Country	USA
Website	RENE

Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.

RENE's peers: PHYT, RRAC, BACA, OAKUU, SCUA, TENK, EMCG, HPLT, BNIX, NRAC, GBBK, ISRL

*Chart delayed

Analyzing fundamentals for RENE we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see RENE Fundamentals page.

Watching at RENE technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on RENE Technicals page.